| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2050* | 2020 |
| The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1491 | 2018 |
| The whole-genome landscape of medulloblastoma subtypes PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ... Nature 547 (7663), 311-317, 2017 | 1074 | 2017 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 909 | 2016 |
| Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma PA Northcott, C Lee, T Zichner, AM Stütz, S Erkek, D Kawauchi, DJH Shih, ... Nature 511 (7510), 428-434, 2014 | 733 | 2014 |
| Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes PD Johann, S Erkek, M Zapatka, K Kerl, I Buchhalter, V Hovestadt, ... Cancer cell 29 (3), 379-393, 2016 | 558 | 2016 |
| Active medulloblastoma enhancers reveal subgroup-specific cellular origins CY Lin, S Erkek, Y Tong, L Yin, AJ Federation, M Zapatka, P Haldipur, ... Nature 530 (7588), 57-62, 2016 | 424 | 2016 |
| Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, ... The Lancet Oncology 19 (6), 785-798, 2018 | 396 | 2018 |
| A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing TS Alioto, I Buchhalter, S Derdak, B Hutter, MD Eldridge, E Hovig, ... Nature communications 6 (1), 1-13, 2015 | 342 | 2015 |
| Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets F Sahm, D Schrimpf, DTW Jones, J Meyer, A Kratz, D Reuss, D Capper, ... Acta neuropathologica 131, 903-910, 2016 | 253 | 2016 |
| The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing I Vater, M Montesinos-Rongen, M Schlesner, A Haake, F Purschke, ... Leukemia 29 (3), 677-685, 2015 | 243 | 2015 |
| Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, ... The Lancet Oncology 19 (6), 768-784, 2018 | 224 | 2018 |
| Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ... Cancer discovery 11 (11), 2780-2795, 2021 | 204 | 2021 |
| Recurrent MET fusion genes represent a drug target in pediatric glioblastoma Nature medicine 22 (11), 1314-1320, 2016 | 189 | 2016 |
| Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03) A Gajjar, GW Robinson, KS Smith, T Lin, TE Merchant, M Chintagumpala, ... Journal of Clinical Oncology 39 (7), 822-835, 2021 | 182 | 2021 |
| Size matters: dissecting key parameters for panel‐based tumor mutational burden analysis I Buchhalter, E Rempel, V Endris, M Allgäuer, O Neumann, AL Volckmar, ... International journal of cancer 144 (4), 848-858, 2019 | 174 | 2019 |
| Germline elongator mutations in sonic hedgehog medulloblastoma SM Waszak, GW Robinson, BL Gudenas, KS Smith, A Forget, M Kojic, ... Nature 580 (7803), 396-401, 2020 | 151 | 2020 |
| The molecular landscape of ETMR at diagnosis and relapse S Lambo, SN Gröbner, T Rausch, SM Waszak, C Schmidt, A Gorthi, ... Nature 576 (7786), 274-280, 2019 | 134 | 2019 |
| EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non‐small … P Christopoulos, V Endris, F Bozorgmehr, M Elsayed, M Kirchner, J Ristau, ... International Journal of Cancer 142 (12), 2589-2598, 2018 | 132 | 2018 |
| Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels V Endris, I Buchhalter, M Allgäuer, E Rempel, A Lier, AL Volckmar, ... International journal of cancer 144 (9), 2303-2312, 2019 | 114 | 2019 |
